Anondita Medicare Bags ₹5.11 Cr International Order from South Africa

Synopsis: Anondita Medicare Limited has received an additional international purchase order worth approximately Rs. 5.11 crore from South Africa-based 1 Stop Medical Supplies for the supply of male condoms. The order further strengthens the company’s export business and reinforces its presence in international healthcare procurement markets.

Shares of Anondita Medicare Limited are likely to remain in focus after the company announced that it has received an additional international purchase order for the supply of male condoms from South Africa.

Anondita Medicare Limited has a total market capitalization of approximately Rs. 2,206.57 crore. The company’s shares were trading at Rs. 1220 apiece on the stock exchange, up by 2.32 percent during the session. The stock has gained 0.43 percent over the last five trading sessions, while it has gained 10.60 percent over the last month. The stock touched a 52-week high of Rs. 1316 and a 52-week low of Rs. 261.

According to the company’s regulatory filing, Anondita Medicare has received an additional purchase order dated June 23, 2026, from 1 Stop Medical Supplies, South Africa, aggregating to approximately Rs. 5.11 crore for the supply and delivery of male condoms.

The company stated that the order is an international contract and is scheduled to be executed by July 31, 2026. It further clarified that the transaction does not involve any promoter or promoter group interest and does not constitute a related-party transaction.

The latest order builds on the company’s earlier qualification under the South African Government tender programme and highlights its growing presence in the international public healthcare procurement market. Export orders from government-backed procurement agencies generally provide better order visibility and strengthen relationships with overseas healthcare distributors.

Global demand for quality contraceptive products continues to be supported by public health initiatives, family planning programmes, and international aid agencies. Governments and healthcare organizations across Africa, Asia, and other emerging markets regularly procure condoms through large-scale tenders to support disease prevention and reproductive healthcare initiatives.

For investors, the additional export order strengthens Anondita Medicare’s revenue visibility while reinforcing its export-oriented growth strategy. Continued participation in international tenders could help the company diversify its customer base, increase export revenues, and improve capacity utilization over the long term.

Founded in 2024, Anondita Medicare Limited manufactures flavored male condoms under its flagship brand “COBRA”. The company focuses on manufacturing and supplying contraceptive products for both domestic and international markets, with increasing emphasis on institutional and export orders.

The latest Rs. 5.11 crore export order further strengthens Anondita Medicare’s international order book and positions the company to benefit from growing global demand for affordable healthcare and family planning products.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Anondita Medicare Bags ₹5.11 Cr International Order from South Africa appeared first on Trade Brains.